GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Defence Therapeutics Inc (XCNQ:DTC) » Definitions » Interest and Commission Paid

Defence Therapeutics (XCNQ:DTC) Interest and Commission Paid


View and export this data going back to 2021. Start your Free Trial

What is Defence Therapeutics Interest and Commission Paid?

Interest and Commission Paid only applicable to companies reporting Cash Flow from Operations in direct method.


Defence Therapeutics Business Description

Traded in Other Exchanges
Address
200 Burrard Street, Suite 1680, Vancouver, BC, CAN, V6C3L6
Defence Therapeutics Inc is engaged in the development of a biological drug enhancer platform that improves the efficacy and safety of a multitude of biological/biosimilar-based pharmaceuticals used in the treatment of cancer and infectious diseases. The Company has one operating segment, being research and development. It operates only in Canada.
Executives
Carrie Cesarone Senior Officer
Patrick Joseph Meagher Director, Senior Officer
Sarkis Meterissian Director
Daniel Kwin Grauer Director